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Background
Hematopoietic stem cell (HSC) transplantation is a stan-
dard procedure in the treatment of hematological disorders
and also applicable to support aggressive chemotherapy in
cancer. In practice, the clinical outcome is often limited by
inefficient bone marrow (BM) engraftment or by low num-
bers of available stem cells. It would therefore be desirable
to enhance engraftment by pharmacological stimulation.
HSC require several signals for successful migration into
the bone marrow. One of these signals is provided by sti-
mulation of Gas[1]. Pretreatment with prostaglandin (PG)
E2 enhances engraftment via activation of Gas-coupled EP2
and EP4 receptors [2]. Treprostinil is a stable analogue of
prostacyclin/PGI2, which acts via IP, EP2 and EP4 receptors
and is approved for treatment of pulmonary hypertension.
Here we tested the hypothesis that treprostinil stimulates
stem cell engraftment.
Methods
Generation of murine bone marrow-derived HSCs: Undif-
ferentiated HSC (lineage-negative, Lin− cells) were isolated
from murine BM, separated by MACS (magnetic-assisted
cell sorting) and characterized by fluorescence-activated
cell sorting (FACS). BM transplantation: Lin− cells were
pretreated in vitro in the absence and presence of 10 µM
treprostinil alone or in combination with 30 µM FSK for
1 h at 37°C. The cellular threshold for successful trans-
plantation was determined by titrating the number of
HSCs required to allow for survival of lethally irradiated
recipient mice. Engraftment and transplantation efficiency
was determined by the analysis of white blood cell counts.
Results
Trepostinil triggered a concentration-dependent accumu-
lation of cAMP in murine Lin− cells with an estimated
EC50 in the range of 0.3 µM. A treprostini-induced cAMP
accumulation was also observed in human HSCs, which
were also shown to express the mRNA encoding IP, EP2
and EP4 receptors. Treprostinil enhanced engraftment of
HSCs; this conclusion is based on the following observa-
tions: (i) mice injected with treprostinil-pretreated Lin−
cells had significantly higher levels of circulating white
blood cells as compared to those receiving vehicle-treated
Lin− cells (p < 0.05, unpaired t-test); (ii) when pretreated
and untreated Lin− cells were mixed to compete for BM
reconstitution, the pretreatment with treprostinil increased
transplantation efficiency 1.5–3-fold; (iii) in vitro pretreat-
ment of HSCs with trepostinil reduced the minimum
number of cells required to rescue a mouse; (iv) engraft-
ment of HSCs was further enhanced when treprostinil was
also administered after injection of the pretreated HSCs.
Conclusions
Treprostinil is suitable for improving haematopoetic
stem cell transplantaion. The observations allow for
designing a protocol to test the compound in a clinical
trial.
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